BD to Invest $35 Million in Nebraska Facility to Expand Prefilled Flush Syringe Manufacturing to Support U.S. Health Care

BD to Invest $35 Million in Nebraska Facility to Expand Prefilled Flush Syringe Manufacturing to Support U.S. Health Care

FRANKLIN LAKES, N.J., Aug. 4, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced plans to invest more than $35 million and add approximately 50 new jobs to expand prefilled flush…

BD announces $35m investment to expand prefilled syringe manufacturing in US

BD has announced an investment exceeding $35m to expand the manufacturing of BD PosiFlush Prefilled Flush Syringes at its US facility.The post BD announces $35m investment to expand prefilled syringe manufacturing in US appeared first on Medical Device Network.

BD invests $35M to expand syringe plant in Nebraska

Becton, Dickinson and Co. plans to invest more than $35 million to expand a prefilled flush syringe manufacturing facility in Nebraska to better meet growing demand from U.S. hospitals and health care systems. In a Aug. 4 press release, Franklin Lakes-based global medical technology company BD said the capital will go toward upgrading product lines, implementing operational efficiencies and supporting product innovation. Along with the ability t…

BD to invest $35M to expand Nebraska syringe manufacturing

The PosiFlush prefilled syringe in use. [Image courtesy of BD] BD (NYSE: BDX) announced today that it plans to invest more than $35 million in U.S.-based prefilled flush syringe manufacturing. The company expects to add approximately 50 new jobs, expanding the manufacturing at its Columbus, Nebraska, facility. BD says it aims to increase the resiliency of the U.S. healthcare system through its latest syringe manufacturing investment. Earlier thi…

BD Says It Will Invest $35M in Nebraska Facility to Expand Syringe Manufacturing

The company expects to add approximately 50 new jobs.